Abstract
Introduction
Patients with idiopathic smell loss constitute an at-risk population for the development of Parkinson’s disease (PD). The study aimed to follow up a large number of patients with idiopathic smell and/or taste loss to define the incidence of PD in this population and, further, to assess characteristics of both olfactory and gustatory function and their possible association with PD development.
Methods
In this prospective case–control study, 833 patients diagnosed with an idiopathic smell disorder at our Smell and Taste Center during the last 15 years were contacted for a telephone interview. In 474 patients, a complete data set containing of demographic data, clinical information, retrospective smell and taste testing results, and telephone assessment was obtained.
Results
Out of 474 patients with idiopathic smell loss 45 (9.8%) had been diagnosed with PD, since they received the diagnosis of idiopathic smell and/or taste loss (mean 10.9 years after olfactory loss onset). Thus, with respect to the classification into olfactory/gustatory disorders, 28.6% of the patients with a combined olfactory and gustatory disorder developed PD, whereas in 9.9% of those with a pure olfactory disorder and in 3.8% of those with a pure gustatory disorder, PD was diagnosed. No association emerged between qualitative smell or taste loss and PD development.
Conclusion
This large patient cohort study extends the previous literature, indicating that risk stratification might be considerably improved by correct diagnostic allocation and emphasizes the need for an exhaustive olfactory and gustatory assessment in specialized centers.



Similar content being viewed by others
References
Hawkes CH, Del Tredici K, Braak H (2010) A timeline for Parkinson’s disease. Parkinsonism Relat Disord 16:79–84
Berendse HW, Roos DS, Raijmakers P, Doty RL (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson’s disease. J Neurol Sci 310:21–24
Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237–1244
Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 62(5):436–446
Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA et al (2009) Prevalence of smell loss in Parkinson’s disease—a multicenter study. Park Relat Disord 15:490–494
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601
Braak H, Del Tredici K, Rub U, de Vos RAI, Jansen Steur ENH, Braak H (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Iannilli E, Stephan L, Hummel T, Reichmann H, Haehner A (2017) Olfactory impairment in Parkinson’s disease is a consequence of central nervous system decline. J Neurol 264(6):1236–1246
Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A et al (2009) Biopsies of olfactory epithelium in patients with Parkinson’s disease. Mov Disord 24(6):906–914
Ponsen MM, Stoffers D, Booij J, van Eck-Smit BLF, Wolters EC, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56:173–181
Ponsen MM, Stoffers D, Twisk JW, Wolters ECH, Berendse HW (2009) Hyposmia and executive dysfunction as predictors of future Parkinson’s disease: a prospective study. Mov Disord 24(7):1060–1065
Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Mov Disord 22:839–842
Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K et al (2008) Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 63:167–173
Berg D, Godau J, Seppi K, Behnke S, Liepelt-Scarfone I, Lerche S et al (2013) The PRIPS study: screening battery for subjects at risk for Parkinson’s disease. Eur J Neurol 20(1):102–108
Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) ‘Sniffin’ Sticks’: olfactory performance assessed by the combined testing of odour identification, odour discrimination and olfactory threshold. Chem Senses 22:39–52
Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the ‘‘Sniffin’ Sticks’’ including tests of odour identification, odour discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264:237–243
Landis BN, Welge-Luessen A, Bramerson A, Bende M, Mueller CA, Nordin S et al (2009) “Taste Strips”—a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers. J Neurol 256:242–248
Gaig C, Tolosa E (2009) When does Parkinson’s disease begin? Mov Disord 24(Suppl 2):S656–S664
Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 64:314–319
Marek K, Jennings D (2009) Can we image premotor Parkinson disease? Neurology 72(Suppl 7):S21–S26
Gaenslen A, Swid I, Liepelt-Scarfone I, Godau J, Berg D (2011) The patients’ perception of prodromal symptoms before the initial diagnosis of Parkinson’s disease. Mov Disord 26(4):653–658
Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R et al (2015) The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord 30(2):229–237
Chen H, Shrestha S, Huang X, Jain S, Guo X, Tranah GJ, Garcia ME, Satterfield S, Phillips C, Harris TB, Health ABC Study (2017) Olfaction and incident Parkinson disease in US white and black older adults. Neurology 89(14):1441–1447
Mahlknecht P, Kiechl S, Willeit J, Poewe W, Seppi K (2018) Reader response: olfaction and incident Parkinson disease in US white and black older adults. Neurology 90(20):940
Landis BN, Reden J, Haehner A (2010) Idiopathic phantosmia: outcome and clinical significance. ORL 72:252–255
Kashihara K, Hanaoka A, Imamura T (2011) Frequency and characteristics of taste impairment in patients with Parkinson’s disease: results of a clinical interview. Intern Med 50:2311–2315
Sienkiewicz-Jarosz H, Scinska A, Kuran W, Ryglewicz D, Rogowski A, Wrobel E et al (2005) Taste responses in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 76:40–46
Lang CJG, Leuschner T, Ulrich K, Stössel C, Heckmann JG, Hummel T (2006) Taste in dementing diseases and parkinsonism. J Neurol Sci 248:177–184
Shah M, Deeb J, Fernando M, Noyce A, Visentin E, Findley LJ et al (2009) Abnormality of taste and smell in Parkinson’s disease. Parkinsonism Relat Disord 15:232–237
Deeb J, Shah M, Muhammed N, Gunasekera R, Gannon K, Findley LJ et al (2010) A basic smell test is a sensitive as dopamine transporter scan: comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson’s disease. QJMed 103:941–952
Kim H-J, Jeon BS, Lee J-Y, Cho Y-J, Hong K-S, Cho J-Y (2011) Taste function in patients with Parkinson disease. J Neurol 258:1076–1079
Cecchini MP, Osculati F, Ottaviani S, Boschi F, Fasano A, Tinazzi M (2014) Taste performance in Parkinson’s disease. J Neural Transm 121:119–122
Acknowledgements
We thank Prof. Ilona Croy for assistance with data analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Haehner, A., Masala, C., Walter, S. et al. Incidence of Parkinson’s disease in a large patient cohort with idiopathic smell and taste loss. J Neurol 266, 339–345 (2019). https://doi.org/10.1007/s00415-018-9135-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-018-9135-x